Posted on 12/7/20
BioCryst Announces $325 Million of Funding from Royalty Pharma and Athyrium Capital Management
NEW YORK and RESEARCH TRIANGLE PARK, N.C., Dec. 07, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX), Royalty Pharma plc (Nasdaq: RPRX) and Athyrium Capital . . .
Posted on 12/2/20
Syneos Health Prices of Secondary Offering of Common Stock
MORRISVILLE, N.C., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO and a CCO . . .
Posted on 12/1/20
Syneos Health Announces Secondary Offering of Common Stock
MORRISVILLE, N.C., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO and a CCO, . . .
Posted on 11/30/20
G1 Therapeutics: Depressed Price Before Catalyst, No Apparent Reason
SummaryGTHX stock is depressed but I don't see any reason.PDUFA of Feb. 15, 2021, is a major catalyst.Label expansion, rest of pipeline, cash runway, collaborations - . . .
Posted on 11/25/20
Syneos Health Closes of $600.0 Million of Senior Notes
MORRISVILLE, N.C., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO and a CCO, . . .
Posted on 11/25/20
Syneos Health Closes Offering of $600M of Senior Notes
MORRISVILLE, N.C., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) . . .
Posted on 11/24/20
vTv Therapeutics Announces Common Stock Purchase Agreement for up to $47M with Lincoln Park Capital
HIGH POINT, N.C., Nov. 24, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) today announced it has entered into a common stock purchase agreement (“Purchase . . .
Posted on 11/19/20
Syneos Health Announces Upsizing and Pricing of Offering of $600M of Senior Notes
MORRISVILLE, N.C., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) . . .
Posted on 11/18/20
Syneos Health Offers Senior Notes
MORRISVILLE, N.C., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) . . .
Posted on 11/16/20
Fennec Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update
RESEARCH TRIANGLE PARK, N.C., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (Nasdaq:FENC; TSX: FRX), a specialty pharmaceutical company focused on the development of PEDMARK . . .
Posted on 11/13/20
Milestone Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical and Corporate Update
Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today reported financial results for the third quarter . . .
Posted on 11/10/20
Precision BioSciences Reports Third Quarter 2020 Financial Results and Provides Business Update
DURHAM, N.C., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL) a clinical-stage biotechnology company dedicated to improving life with its novel and proprietary . . .
Posted on 11/6/20
FDA Grants Emergency Use Authorization for Proprietary Mask from HanesBrands
The U.S. Food and Drug Administration issued an emergency use authorization for a proprietary mask developed by HanesBrands along with researchers from the University of North . . .
Posted on 11/5/20
Chimerix Misses Q3 Estimates by a Penny
Biopharmaceutical company Chimerix missed earnings estimates slightly with a third-quarter net loss of 18 cents per basic and diluted share, up from a loss of $1.26 . . .
Posted on 11/5/20
BioCryst Reports Third Quarter 2020 Financial Results
RESEARCH TRIANGLE PARK, N.C., Nov. 05, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced financial results for the third quarter ended September 30, 2020, . . .
Posted on 11/5/20
BioDelivery Sciences Reports Strong Q3 2020 Results
RALEIGH, N.C., Nov. 05, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious . . .
Posted on 11/5/20
BioDelivery Sciences Announces $25 Million Share Repurchase Program
RALEIGH, N.C., Nov. 04, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious . . .
Posted on 11/5/20
BioDelivery Sciences Announces $25 Million Share Repurchase Program
RALEIGH, N.C., Nov. 04, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious . . .
Posted on 11/5/20
G1 Therapeutics Provides Financial Update
RESEARCH TRIANGLE PARK, N.C., Nov. 04, 2020 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today provided a corporate and financial update . . .
Posted on 11/4/20
Novan Receives Approval to Transfer to Nasdaq Capital Market
MORRISVILLE, N.C., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. (Nasdaq: NOVN), today announced that on November 3, 2020, the Listing Qualifications department of The Nasdaq . . .
Posted on 10/30/20
Novan Reports Third Quarter 2020 Financial Results and Provides Corporate Update
MORRISVILLE, N.C., Oct. 30, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. (Nasdaq: NOVN), today announced its financial results for the quarter ended September 30, 2020 and provided . . .
Posted on 10/29/20
Syneos Health Reports Third Quarter 2020 Results
MORRISVILLE, N.C., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), a leading biopharmaceutical solutions organization combining a Contract Research Organization and a Contract Commercial Organization, . . .
Posted on 10/27/20
LabCorp Announces 2020 Third Quarter Results
BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH) today announced results for the third quarter ended September 30, 2020.“LabCorp remains committed to fighting the pandemic through innovations in testing . . .
Posted on 10/27/20
Aerie Pharmaceuticals to Announce Third Quarter 2020 Financial Results
DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with . . .
Posted on 10/26/20
Bayer Acquires Asklepios BioPharmaceutical
Bayer AG today announced the acquisition of Asklepios BioPharmaceutical, Inc. (AskBio), a US-headquartered biopharmaceutical company specialized in the research, development a
Charlotte Raleigh
